Henry Benjamin Armatei Armah

Title: Henry Benjamin Armatei Armah: Innovator in Malaria Diagnosis

Introduction

Henry Benjamin Armatei Armah is a notable inventor based in Mount Pleasant, MI (US). He has made significant contributions to the field of medical diagnostics, particularly in the management of malaria. His innovative work focuses on identifying biomarkers that can predict the severity of malaria, which is crucial for improving patient outcomes.

Latest Patents

Henry Benjamin Armatei Armah holds a patent for "Compositions and methods for diagnosis, prognosis and management of malaria." This patent discloses biomarkers such as CXCL4, CXCL10, VEGF, PGDF, IL-1Ra, IL-8, MIP-1β, sFas, Fas-L, sTNF-R2, and sTNF-R1, which are essential for predicting the severity of malaria. The patent also outlines a method for determining the severity of malaria and predicting mortality due to cerebral malaria by analyzing the expression ratios of these biomarkers.

Career Highlights

Armah is affiliated with the Morehouse School of Medicine, where he continues to advance research in malaria diagnostics. His work is pivotal in developing methods that can lead to better management and treatment of malaria, a disease that affects millions worldwide.

Collaborations

He has collaborated with esteemed colleagues such as Jonathan K Stiles and James W Lillard, Jr., contributing to a rich environment of research and innovation.

Conclusion

Henry Benjamin Armatei Armah's contributions to malaria diagnostics exemplify the impact of innovative research in healthcare. His work not only enhances our understanding of malaria but also paves the way for improved diagnostic methods that can save lives.